Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Medpace Holdings, Inc. shareholders approved Advisory Vote on the Compensation of our Named Executive Officers at the 2023-05-19 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-05-19
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.07. Submission of Matters to a Vote of Security Holders. (a) On May 19, 2023, Medpace Holdings, Inc. (the "Company") held its 2023 Annual Meeting of Stockholders. (b) Stockholders voted on the matters set forth below. Proposal 1 - Election of Directors The following nominees were elected to the Company’s Board of Directors to serve as Class I Directors until the Company’s 2026 Annual Meeting of Stockholders based upon the following votes: Votes For Votes Withheld Broker Non-Votes Brian T. Carley 15,744,076 12,066,720 1,172,784 Femida H. Gwadry-Sridhar 27,027,873 782,923 1,172,784 Robert O. Kraft 15,166,913 12,643,883 1,172,784 Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company’s i
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Medpace Holdings, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-19 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-19
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.07. Submission of Matters to a Vote of Security Holders. (a) On May 19, 2023, Medpace Holdings, Inc. (the "Company") held its 2023 Annual Meeting of Stockholders. (b) Stockholders voted on the matters set forth below. Proposal 1 - Election of Directors The following nominees were elected to the Company’s Board of Directors to serve as Class I Directors until the Company’s 2026 Annual Meeting of Stockholders based upon the following votes: Votes For Votes Withheld Broker Non-Votes Brian T. Carley 15,744,076 12,066,720 1,172,784 Femida H. Gwadry-Sridhar 27,027,873 782,923 1,172,784 Robert O. Kraft 15,166,913 12,643,883 1,172,784 Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company’s i
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Medpace Holdings, Inc. shareholders approved Election of Directors at the 2023-05-19 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-19
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.07. Submission of Matters to a Vote of Security Holders. (a) On May 19, 2023, Medpace Holdings, Inc. (the "Company") held its 2023 Annual Meeting of Stockholders. (b) Stockholders voted on the matters set forth below. Proposal 1 - Election of Directors The following nominees were elected to the Company’s Board of Directors to serve as Class I Directors until the Company’s 2026 Annual Meeting of Stockholders based upon the following votes: Votes For Votes Withheld Broker Non-Votes Brian T. Carley 15,744,076 12,066,720 1,172,784 Femida H. Gwadry-Sridhar 27,027,873 782,923 1,172,784 Robert O. Kraft 15,166,913 12,643,883 1,172,784 Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company’s i
View on SEC.gov